These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 20800862

  • 21. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden.
    Spillane AJ, Pasquali S, Haydu LE, Thompson JF.
    Ann Surg Oncol; 2014 Jan; 21(1):292-9. PubMed ID: 24052314
    [Abstract] [Full Text] [Related]

  • 22. [PET scanning for malignant melanoma and positive sentinel node diagnostics].
    Horn J, Sjøstrand H, Lock-Andersen J, Loft A.
    Ugeskr Laeger; 2010 Apr 12; 172(15):1126-30. PubMed ID: 20427004
    [Abstract] [Full Text] [Related]

  • 23. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB, Soo V, Kraas J, Shen P, Levine EA.
    Arch Surg; 2006 Mar 12; 141(3):284-8. PubMed ID: 16549694
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
    Constantinidou A, Hofman M, O'Doherty M, Acland KM, Healy C, Harries M.
    Melanoma Res; 2008 Feb 12; 18(1):56-60. PubMed ID: 18227709
    [Abstract] [Full Text] [Related]

  • 26. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
    Starz H, Balda BR.
    Int J Cancer; 2007 Aug 01; 121(3):689-93. PubMed ID: 17397029
    [Abstract] [Full Text] [Related]

  • 27. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI, Rutkowski P, Michej W.
    Ann Surg Oncol; 2008 Aug 01; 15(8):2223-34. PubMed ID: 18506535
    [Abstract] [Full Text] [Related]

  • 28. Baseline staging in cutaneous malignant melanoma.
    Hafner J, Schmid MH, Kempf W, Burg G, Künzi W, Meuli-Simmen C, Neff P, Meyer V, Mihic D, Garzoli E, Jungius KP, Seifert B, Dummer R, Steinert H.
    Br J Dermatol; 2004 Apr 01; 150(4):677-86. PubMed ID: 15099363
    [Abstract] [Full Text] [Related]

  • 29. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL.
    Arch Surg; 2006 Sep 01; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [Abstract] [Full Text] [Related]

  • 30. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, MSLT Group.
    N Engl J Med; 2006 Sep 28; 355(13):1307-17. PubMed ID: 17005948
    [Abstract] [Full Text] [Related]

  • 31. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
    Gutzmer R, Al Ghazal M, Geerlings H, Kapp A.
    Br J Dermatol; 2005 Dec 28; 153(6):1137-41. PubMed ID: 16307648
    [Abstract] [Full Text] [Related]

  • 32. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M, Rutkowski P, Nowecki ZI, van Akkooi AC, Michej W, Dziewirski W, Świtaj T, Pieńkowski A, Sałamacha M, Bylina E, Eggermont AM.
    Eur J Surg Oncol; 2013 Mar 28; 39(3):304-10. PubMed ID: 23298828
    [Abstract] [Full Text] [Related]

  • 33. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V, Breuninger H, Garbe C, Moehrle M.
    Br J Dermatol; 2006 Feb 28; 154(2):310-8. PubMed ID: 16433802
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P, Nowecki ZI, Zurawski Z, Dziewirski W, Nasierowska-Guttmejer A, Switaj T, Ruka W.
    Eur J Cancer; 2006 Jan 28; 42(2):159-64. PubMed ID: 16324835
    [Abstract] [Full Text] [Related]

  • 38. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO, Yeh JJ, Frank J, Long P, Deal AM, Amos KD, Ollila DW.
    Ann Surg Oncol; 2009 Apr 28; 16(4):941-7. PubMed ID: 19101766
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.